Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Offering patients a clinician team roster increases recognition and involvement

Offering patients a roster of clinicians on their care team increased recognition of each clinician's name and face during their treatment period, something patients also reported as highly significant to their care, according to research presented at American College of Cardiology Quality Summit Virtual, taking place Sept. 29 – Oct. 1, 2021.

29 Sep 2021

Buck Institute receives $14 million NIH grant to focus on one of the major drivers of aging

Buck Institute professors Judith Campisi, PhD and Lisa Ellerby PhD, have been awarded a $14.3 million grant from the NIH's National Institute of Aging to study cellular senescence, one of the major hallmarks of aging, as a driver of Alzheimer's disease and other age-related dementias.

29 Sep 2021

Alzheimer’s drug targets people with mild cognitive impairment. What does that mean?

The approval of a controversial new drug for Alzheimer's disease, Aduhelm, is shining a spotlight on mild cognitive impairment — problems with memory, attention, language or other cognitive tasks that exceed changes expected with normal aging.

29 Sep 2021

Low frequency rTMS can improve memory performance, study shows

Memories of past events and experiences are what define us as who we are, and yet the ability to form these episodic memories declines with age, certain dementias, and brain injury.

29 Sep 2021

Researchers develop new mouse model for studying non-Demented with Alzheimer’s disease

Alzheimer's is a neurodegenerative disease that features the accumulation of the beta-amyloid peptide and Tau protein in the brain, which are associated with deficits in the neuronal connections and with dementia.

28 Sep 2021

Seven symptoms can be used to maximize detection of COVID-19

A set of 7 symptoms, considered together, can be used to maximize detection of COVID-19 in the community, according to a new paper published this week in PLOS Medicine by Marc Chadeau-Hyam and Paul Elliott of Imperial College London, UK, and colleagues.

28 Sep 2021

Depression in early adulthood may lead to cognitive decline in old age

While research has shown that poor cardiovascular health can damage blood flow to the brain increasing the risk for dementia, a new study led by UC San Francisco indicates that poor mental health may also take its toll on cognition.

28 Sep 2021

UNLV neuroscientists bolster the connection between Type II diabetes and Alzheimer's disease

A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer's disease.

28 Sep 2021

Feeling happy about life reduces the odds of cognitive impairment in older adults

Feeling happy about life slowed the cognitive decline among older adults in China, a new 12-year study suggests.

28 Sep 2021

Study maps hotspots of low-value care use at individual health systems

Researchers estimate that up to $101 billion in health care spending is wasted each year due to over-treatment or the delivery of "low-value care." Low-value care includes a wide array of tests and treatments that are medically unnecessary and for which the potential for harm outweigh the potential for benefit. While researchers have charted the ongoing use of low-value care on national and regional levels, little research exists on how health systems across the country use low-value care and how they compare to each other.

28 Sep 2021

Brain communication networks altered during drug withdrawal, mice study shows

Zeroing in on specific brain regions when studying drug and alcohol abuse simplifies research but may leave out important insights.

27 Sep 2021

Inexpensive anti-seizure drug benefits Alzheimer's patients with silent epileptic activity

An inexpensive anti-seizure medication markedly improves learning and memory and other cognitive functions in Alzheimer's patients who have epileptic activity in their brains, according to a study published in the Sept. 27th issue of JAMA Neurology.

27 Sep 2021

Withdrawal from psychostimulants alters functional architecture and patterns in the brain

Addictive psychostimulants, from nicotine in cigarettes to illicit drugs like methamphetamine and cocaine, affect different regions of the brain. The same is believed true during withdrawal; finding a common brain pathway has proved elusive.

27 Sep 2021

New blood test to diagnose Alzheimer's disease using atomic force microscopy

If the suspicion of Alzheimer's disease creeps up, those affected must prepare themselves for lengthy and complex procedures until the case is clear.

27 Sep 2021

MHRI aims to delve deeper into how musical intervention can affect health

If popular wisdom holds that music is good for the soul, science is increasingly seeking to better understand how music can affect the body, brain, and mind, as evidenced by the 2020 publication of the first World Health Organization report on health and music.

24 Sep 2021

Researchers discover how Rift Valley fever virus enters cells

Rift Valley fever virus causes economically devastating outbreaks of hemorrhagic fever in livestock such as sheep, goats and cattle.

24 Sep 2021

NIH-funded project to test light therapies to combat Alzheimer’s debilitating effects

Alzheimer's disease is a mind-robbing brain disorder that affects nearly 6.2 million older Americans. Despite decades of research on high-tech drugs, diets, and crossword puzzles, scientists have yet to discover a highly effective treatment for patients.

23 Sep 2021

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Offering patients a clinician team roster increases recognition and involvement

Buck Institute receives $14 million NIH grant to focus on one of the major drivers of aging

Alzheimer’s drug targets people with mild cognitive impairment. What does that mean?

Low frequency rTMS can improve memory performance, study shows

Researchers develop new mouse model for studying non-Demented with Alzheimer’s disease

Seven symptoms can be used to maximize detection of COVID-19

Depression in early adulthood may lead to cognitive decline in old age

UNLV neuroscientists bolster the connection between Type II diabetes and Alzheimer's disease

Feeling happy about life reduces the odds of cognitive impairment in older adults

Study maps hotspots of low-value care use at individual health systems

Brain communication networks altered during drug withdrawal, mice study shows

Inexpensive anti-seizure drug benefits Alzheimer's patients with silent epileptic activity

Withdrawal from psychostimulants alters functional architecture and patterns in the brain

New blood test to diagnose Alzheimer's disease using atomic force microscopy

MHRI aims to delve deeper into how musical intervention can affect health

Researchers discover how Rift Valley fever virus enters cells

NIH-funded project to test light therapies to combat Alzheimer’s debilitating effects

The checkup is in the mail? Soliciting letter carriers to help deliver health care

Discovery points toward a new strategy for treating Parkinson's disease

Study provides clearer understanding of how migraines affect sleep patterns

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in